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Abstract According to the Declaration of Helsinki, participa-
tion of human subjects in medical research is only acceptable
if subjects have given their consent. But in child abuse and
neglect, many studies use a design in which subjects do not
actively participate. Data in these studies are gathered from
sources such as medical records or Child Protective Services.
As long as such data are used anonymously, this does not
interfere with individual privacy rights. However, some re-
search is only possible when carried out with personally
identifiable data, which could potentially be misused. In
this paper, we discuss in which situations and under which
conditions personal data of children may be used for a
study without obtaining consent. In doing so, we make
use of two recent studies, performed in our hospital, in
which we encountered this issue. Both studies involved
collecting personal data. After careful consideration, we
decided not to ask informed consent; instead, we arranged
for specific safeguards to protect the subject’s and their
parents’ privacy as well as possible.
Conclusion: Altogether, we conclude that our approach fits
within the Dutch legal framework and seems a reasonable
solution in situations in which individual privacy rights are
at odds with the public interest of child abuse and neglect
research. We argue that, although, in principle, data research
is only acceptable after informed consent is obtained, the law
should allow that, under specific circumstances and safe-
guards, this requirement is put aside to make research in the
field of child abuse and neglect possible.
What is known:
• In principle, data research is only acceptable after informed consent is
obtained.
• In practice, this is not always feasible.
What is new:
• Under specific circumstances and safeguards, the informed consent
requirement can be put aside.
Keywords Child abuse . Research . Privacy/legislation&
jurisprudence . Informed consent (byminors) . Parental
informed consent
Abbreviations
AMK Child Abuse Counseling and Reporting Centre (in
Dutch: Advies en Meldpunt Kindermishandeling)
EU European Union
RvdK Child Care and Protection Board (in Dutch: Raad
voor de Kinderbescherming)
Introduction
According to the Declaration of Helsinki, participation of hu-
man subjects in medical research is only acceptable if subjects
(or their legal representatives—e.g., parents) are fully
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informed of all aspects of the study and have given their con-
sent [23]. However, in the field of child abuse and neglect,
many studies use a design in which subjects do not actively
participate. Such studies make use of available data about the
children, their parents, and applied (health care) services and
interventions to reduce child abuse and neglect. These data are
gathered from sources such as medical records [10], records of
Child Protective Services [22], and data provided by commu-
nity services [18]. As long as such data are used anonymously,
this does not interfere with individual privacy rights of the
involved research subjects (which could be both the child
and his or her parents). But in some situations, the use of
anonymous data does not suffice, e.g., because the data needs
deduplication or linking to data from other sources. In these
situations, it is necessary to use personally identifiable (or
personal) data, meaning that it is reasonably possible to trace
an individual’s identity from the data (i.e., without a dispro-
portionate use of means available to identify the person to
whom the information relates). The use of such data could
potentially cause problems or harm to the subjects or their
parents when it is misused or ends up in wrong hands.
In research that is carried out in our hospital, we aim at
linking data from different sources (medical records, records
of Child Protective Services and community services, and
self-reported data). This is only possible by using personal
data. Whereas, we know that, in principle, all subjects should
provide informed consent before their data is used, we expe-
rience that this is often not feasible, e.g., because the child and
his or her parents are not traceable or—in case of large-scale
database studies—it lacks means and time to approach each
individual subject. Another problem is that in child abuse
research, asking for informed consent may lead to a serious
non-response bias [2, 11]. In this paper, we discuss in which
situations and under which conditions a research project could
be performed without obtaining informed consent of the re-
search subjects. In doing so, we refer to two recent studies in
our hospital in which we encountered these issues.
Data research: two examples
Example 1: evaluation of a protocol to identify child abuse
and neglect
We conducted a study to evaluate a recently implemented
hospital-based guidance protocol to improve identification of
abused or neglected children in hospitals. This new protocol
was based on a protocol developed in The Hague,
The Netherlands in 2007 [8]. In the new protocol, all adults
attending the emergency department because of medical prob-
lems due to intimate partner violence, substance abuse, or a
suicide attempt were asked whether they care for children
under 18 years of age. If so, children and their parents were
referred to the outpatient pediatric department for an exami-
nation. After this visit, referrals to services could be arranged.
If parents refused to cooperate after several reminders, chil-
dren were reported to the Child Abuse Counseling and
Reporting Centre (in Dutch: Advies en Meldpunt
Kindermishandeling, AMK) [12]. If necessary, the AMK
could decide to hand over serious cases to the Child Care
and Pro tec t ion Board ( in Dutch : Raad voor de
Kinderbescherming, RvdK), which is a division of the Minis-
try of Security and Justice [21]. To evaluate this protocol, we
used several outcome measures. First, we used parent- and
child-reported outcomes, for which we asked informed con-
sent. However, based on previous studies and the opinion of
other authors, we expected a low participation rate [7, 11, 20].
We were concerned that there would be a substantial non-
response bias that would severely limit the external validity
of the results. We expected that eligible subjects who were
unwilling to participate in the study suffered from more prob-
lems than subjects who were willing to participate [4, 13–15].
In order to collect results from an unselected group, we
wanted to include reports of hospital staff, AMK records,
and RvdK records of all eligible subjects in the study (thus
without asking for informed consent). Therefore, we would
need to search AMK and RvdK records, and we needed to ask
information from hospital staff. We could not use anonymous
data, because we wanted to link data from different sources
and, because the study was conducted in multiple hospitals,
deduplicate. (Hospital staff could be unaware if subjects vis-
ited multiple hospitals during the study period).
Example 2: validation of a screening test for child abuse
and neglect
We conducted a study that aimed to validate two (already
implemented) screening tests to identify child abuse and ne-
glect at the hospital emergency department: a checklist called
SPUTOVAMO and a complete physical inspection. All chil-
dren visiting the emergency department underwent screening
and were included in the study. As a reference standard, a
multidisciplinary child protection team evaluated children
with a positive screening result on either of the tests and
assessed the presence of (a suspicion of) child abuse and ne-
glect. This was all part of usual clinical care; data were used
anonymously, and children and parents were not asked to
provide informed consent. As a next step, however, we
wanted to evaluate the proportion of false negative test results.
These were children with negative results on both screening
tests who were in reality victims of child abuse and neglect.
For these children, and for children who had a positive screen-
ing test but were not evaluated by the multidisciplinary child
protection team (missed diagnosis), we wanted to use AMK
reports as a proxy reference standard for a child abuse diag-
nosis. Therefore, we needed to search the AMK database,
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which is not part of usual care and would require the use of
personal identifiable data. After consideration, we did not
want to ask informed consent for the AMK database search
because, as with the previous study, we were concerned
that parents who were maltreating their children would be
less inclined to participate in the study. This would result in
an overestimation of the sensitivity of the screening tests,
with potentially dangerous consequences for future,
maltreated children.
Solution
After discussing our dilemma in a multidisciplinary team (in-
cluding a hospital lawyer specialized in privacy matters, a
dedicated hospital privacy officer, and a pediatrician special-
ized in child abuse and neglect), we used the following proto-
col in handling personal data: in both studies, only the main
researcher (after signing a confidentiality agreement) searched
for Bhits^ in the AMK and RvdK records. In the context of our
approach, we could not inform subjects individually about our
study, but in the majority of the participating hospitals, the
general hospital leaflet contains a statement that, without ob-
jection, personal medical information can be used for research
and patients will never be identifiable in any publications.
There are instructions on how to object to this. If subjects
would raise an objection against the use of their personal in-
formation in research, all information would be destroyed im-
mediately. In the first study, only the main researcher collected
all data from hospital staff. The researcher asked the staff to
make a notification about participation in our study in the
subjects’ records. During the study, all personal information
was coded, and a key list was only kept by a trusted third party
(a senior researcher, who was experienced in the field but not
involved in the study). As soon as all data analyses were
finished, all personal information was destroyed carefully.
Legal framework for data research
European level
When medical data research is involved, the main rules are
provided by binding legislation (Bhard law^) of the European
Union (EU). We refer at a directive, adopted in 1995, on the
protection of individuals with regard to the processing of per-
sonal data and on the free movement of such data (Directive
95/46/EC) [9]. By now, all EU-member states incorporated
the directive’s provisions into their national laws. Although
its framework on handling personal data of a particular sensi-
tive nature, which medical data clearly are, is strict, it takes
into account the importance of data processing for scientific
research (in the medical field). It allows that the rights of
individual Bdata subjects^ (e.g., patients) are restricted when
data processing for important research purposes is involved.
The directive offers no more than a general legal framework.
In this area, non-binding (Bsoft law^) rules and principles,
developed by, e.g., the Council of Europe and the European
Science Foundation, provide further guidance. The main
principle embodied in these (binding and non-binding)
documents is that medical data which are not anonymous,
but (directly or indirectly) identifiable, may be collected
and used for a research project if the data subject or his/
her legal representative has given informed consent. How-
ever, when—despite reasonable efforts—it would be impracti-
cable to seek the individual’s consent, the data may be gathered
without the individual’s explicit consent, provided that certain
conditions are met. One of these conditions is that the data
subject knows about the possible use of his or her data for
scientific research (right to be informed on a general level)
and has not objected to this (right to Bopt-out^) [16].
Presently, the European Union is in the middle of
reforming the data protection framework. It is developing
the so-called General Data Protection Regulation (GDPR),
which is not only binding to the EU-member states (as the
Directive) but also directly applicable in the member states,
making implementation unnecessary. Because the draft regu-
lation, once adopted, may leave less room for research with
medical data than the present EU-framework, i.e., by provid-
ing stricter conditions for research in situations in which it
would be impracticable to seek the individual’s consent, it is
subject to strong debate inside and outside the medical re-
search community [1, 17, 19]. It is important to note that, in
June 2015, the Council of Ministers proposed a version of the
GDPR that leaves substantially more room for research than
the proposal of the European Parliament from May 2014; on
the basis of the council’s version, broad consent seems to be
possible, and further regulation of research without consent is
left to the legislation of the member states [5]. However, the
three EU-bodies (Council of Ministers, European Parliament,
and European Commission) have to negotiate about the final
text. This is not expected before the end of 2015.
National level
In The Netherlands, in the context of medical data research,
two laws are relevant: the Personal Data Protection Act (in
Dutch: BWet bescherming persoonsgegevens^) and the Med-
ical Contract Act (in Dutch: Wet inzake de geneeskundige
behandelingsovereenkomst), a section of the Dutch Civil
Code. Here, we pay only attention to the latter because that
is the one that provides specific rules for disclosing patient
data for medical research. On the basis of Article 7:457 Civil
Code, a physician or caregiver may disclose identifiable
patient data to researchers when the patient authorized
the disclosure. However, when obtaining consent appears
to be impossible or would involve a disproportionate
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effort, that requirement may be dropped under the follow-
ing conditions. First, the research project should serve a
public interest; second, the research could not be carried
out without the data concerned; third, the data subject is
informed about the possible use of his/her data for research
and has not explicitly opposed to this; and fourth, adequate
security measures (technical and organizational) are taken
(e.g., encoding the data).
We would like to note that, whereas this framework fits
within the present EU-directive, it might come in conflict with
the future EU-regulation.
Discussion
In child abuse and neglect research, studies using linkable data
of unselected samples are often necessary to yield unbiased
results of sufficient quality. Since the results of these studies
can have important consequences for the social, mental, and
medical well-being of maltreated children and their families,
we argue that, in very specific circumstances, it should be
possible to perform such research without informed consent
of the child and/or the parents involved. In this paper, we
presented two examples: the first was evaluating a new pro-
tocol implemented to identify child abuse and neglect by
assessing high risk parents, and the second was evaluating
the diagnostic accuracy of two screening tools for maltreat-
ment used in children at the emergency department. The most
important reason not to ask informed consent was that we
expected a severe non-response bias if we would only include
families who were willing to participate. In both studies, the
screening methods to identify child abuse and neglect that we
wanted to investigate were already implemented in clinical
care, although they had never been evaluated. We believe that
good quality evaluation research is very important. However,
in carrying out such research, the protection of privacy of
research subjects may not, or at least as minimal as possible,
be compromised. And for researchers, it is also very important
that the performance of the study may not come into conflict
with legal standards. According to Dutch law (Medical Con-
tract Act; see before), consent can only be dropped if the
research project serves a public interest, the project could
not be carried out without the requested data, and the stored
data are well secured by encoding them. And last but not least,
the data subject is informed about the possible use of his/her
data for research and has not explicitly opposed to this. With
our approach, we were able to fulfill those conditions: the
studies serve a public interest and could not be carried out
without the data involved. As illustrated by the two examples
as described before, we took several safeguards to ensure that
the privacy of research subjects was protected as much as
possible. First, we used an approach in which only the main
researcher had access to personal data and no information was
handed over to other parties (such as the AMK). In this way,
the other parties could never use any information from the
study in a way that could potentially negatively affect research
subjects. If we would have asked the AMK to look for hits of
our study participants in their databases, AMK staff could
have used this information in their clinical assessments, which
could have had consequences for the study subjects. The
downside of having the researcher searching in databases of
other parties is that the researcher could look up extra, non-
relevant, information of study subjects or other persons, thus
violating the privacy of these persons. Other than signing a
confidentiality agreement, we could not be 100 % sure that
this would not happen. Another safeguard was immediate
coding of personal information, meaning that—by making
use of a trusted third party (based in a different department
of our institution)—all personal data were stored separately
from the research data. By doing so, although not completely
avoided, the risk that meaningful personal information would
end up in wrong hands was minimal. We would like to note,
however, that if financially feasible, it would be preferable, to
use a completely independent trusted third party as a linkage
center [3]. In this way, personal data are coded at the linkage
center before any other information is retrieved from parties
and send to researchers, and neither the other parties (such as
the AMK) nor the researcher has access to any additional data
[3]. Furthermore, research subjects and/or their representa-
tives were informed about the possibility that their data could
be used for medical research in general by a statement in the
hospital leaflet or on the hospital website.
Final remarks
In this paper, we discussed an approach to conduct research
about child abuse and neglect without obtaining informed
consent. This approach is consistent with the Dutch legal
framework (therefore: the Dutch approach) and may be valu-
able for other countries. However, we argue that some im-
provements should be made.
First, we only partly fulfilled the Bopt-out^ condition for
research subjects, because, although in theory, patients could
read a statement about research based on patient records and
instructions to object, most patients were probably not aware
of this. We therefore recommend an improved opt-out proce-
dure in the sense that it is better secured that patients and/or
their legal representatives are really aware of the fact that their
medical records could be used in research, and that they are
always entitled to object to such use. This information should
be available explicitly; hospitals could develop special leaflets
for using medical data for research and put these posters or
leaflets in waiting rooms, and the information could be put
prominent on their websites. To prevent that patients opt out
without even considering their participation, it should be
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clearly explained that the research is used to improve medical
care, that personal information will never be distributed or
published, and that patients will not experience any negative
consequences. We think that a general leaflet, distributed to all
patients visiting the hospital, informing and explaining them
in clear and accessible language about the possibility of using
their data for research purposes, would be the best way to go.
In that way, patients will understand that data research is a
normal part of healthcare.
Second, when researchers refrain from obtaining informed
consent while they make use of personal data, we recommend
a review of the research proposal by a medical ethics commit-
tee (MEC) or comparable body, especially in sensitive re-
search areas as on child abuse and neglect. Although this is
not a current requirement under Dutch law, it is recom-
mended by non-binding documents such as the Council
of Europe’s Recommendation No. R (97) 5 on the Protec-
tion of Medical Data (February 13, 1997) [6] (see Article
12.2 sub c). Although hospital or university medical ethics
committees have no authority over external organizations
that provide data, such as the AMK, they do have authority
over the researchers working in their own institution. If
their MEC does not approve the research protocol, the re-
searcher is not allowed to proceed with the study. It would
be even more careful if external organizations, such as the
AMK, would only cooperate with extraction from its data-
base if researchers hand over a MEC approval.
We would like to conclude that this approach seems a rea-
sonable solution in situations in which individual privacy
rights are at odds with the public interest of child abuse and
neglect research. We argue that—although, in principle, med-
ical research with human subjects is only acceptable after
informed consent is obtained—European and national law
should allow that under certain circumstances and safeguards
the informed consent requirement is put aside to avoid that
research in the field of child abuse will be (come) impossible.
Acknowledgments This study was funded by the Stichting
Kinderpostzegels Nederland (an independent children's charity) and the
city of Amsterdam. The funders had no role in conducting and designing
this study, collecting, managing and interpreting the data, and writing the
manuscript.
Authors’ contributions MP first had the idea to write this manu-
script, EHvK drafted the first manuscript, EHvK and AT were the
main researchers of the two described studies, and MP and AT
revised the manuscript. All authors approved the final version of
this manuscript.
Compliance with ethical standards This article does not contain re-
sults of studies with human participants; however, two other studies with
human participants are described. We discuss them in accordance with
institutional, national and international guidelines, including informed
consent.
Conflict of interest The authors declare that they have no competing
interests.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. (2015) Data overprotection. Nature 522:391–392. doi: 10.1038/
522391b
2. Berry V (2009) Ethical considerations in conducting family vio-
lence research . Res Eth ics 5 :91–100. doi :10 .1177 /
174701610900500302
3. Brownell MD, Jutte DP (2013) Administrative data linkage as a
tool for child maltreatment research. Child Abuse Negl 37:120–
124. doi:10.1016/j.chiabu.2012.09.013
4. Chae Y, Goodman GS, Bederian-Gardner D, Lindsay A (2011)
Methodological issues and practical strategies in research on child
maltreatment victims' abilities and experiences as witnesses. Child
Abuse Negl 35:240–248. doi:10.1016/j.chiabu.2010.12.006
5. Coppen R, van Veen EB, Groenewegen PP et al (2015) Will the
trilogue on the EU Data Protection Regulation recognise the impor-
tance of health research? Eur J Public Health 25:757–758. doi:10.
1093/eurpub/ckv149
6. Council of Europe (1997) Recommendation No. R (97) 5 on the
protection of medical data. Available via: https://www1.umn.edu/
humanrts/instree/coerecr97-5.html
7. Diderich HM, Fekkes M, Dechesne M et al (2015) Detecting child
abuse based on parental characteristics: does the Hague Protocol
cause parents to avoid the emergency department? Int Emerg Nurs
23:203–206. doi:10.1016/j.ienj.2014.09.004
8. Diderich HM, Fekkes M, Verkerk PH et al (2013) A new protocol
for screening adults presenting with their own medical problems at
the emergency department to identify children at high risk for mal-
treatment. Child Abuse Negl 37:1122–1131. doi:10.1016/j.chiabu.
2013.04.005
9. European Commission (2012) Proposal for a regulation of the
European Parliament and of the Council on the protection of indi-
viduals with regard to the processing of personal data and on the
free movement of such data (General Data Protection Regulation).
Available via http://ec.europa.eu/justice/data-protection/law/index_
en.htm.
10. Farst K, Ambadwar PB, King AJ et al (2013) Trends in hospitali-
zation rates and severity of injuries from abuse in young children,
1997–2009. Pediatr 131:e1796–e1802. doi:10.1542/peds.2012-
1464
11. Higgs S, Finlay F (2014) Ethical considerations involved in seeking
the views of young people and their parents on medical reports
received following a child protection medical examination. Child
Abuse Rev 23:374–381. doi:10.1002/car.2267
12. Hoytema van Konijnenburg EMM, Sieswerda-Hoogendoorn T,
Brilleslijper-Kater SN et al (2013) New hospital-based policy for
children whose parents present at the ER due to domestic violence,
substance abuse and/or a suicide attempt. Eur J Pediatr 172:207–
214. doi:10.1007/s00431-012-1869-3
13. Kinard EM (1994) Methodological issues and practical problems in
conducting research on maltreated children. Child Abuse Negl 18:
645–656. doi:10.1016/0145-2134(94)90014-0
14. Lynch DL, Stern AE, Oates RK, O'Toole BI (1993) Who partici-
pates in child sexual abuse research? J Child Psychol Psychiatry 34:
935–944. doi:10.1111/j.1469-7610.1993.tb01099.x
Eur J Pediatr (2015) 174:1573–1578 1577
15. Paradise JE, Rose L, Sleeper LA, Nathanson M (1994) Behavior,
family function, school performance, and predictors of persistent
disturbance in sexually abused children. Pediatrics 93:452–459
16. PloemMC (2006) Towards an appropriate privacy regime for med-
ical data research. Eur J Health Law 13:41–63. doi:10.1163/
157180906777036319
17. Ploem MC, Essink-Bot ML, Stronks K (2013) Proposed EU data
protection regulation is a threat to medical research. BMJ 346:
f3534–f3534. doi:10.1136/bmj.f3534
18. Sedlak AJ, Mettenburg J, Basena M, et al. (2010) Fourth National
Incidence Study of Child Abuse and Neglect (NIS–4). 1–455
19. Se th i N (2014) The promot ion of da ta sha r ing in
pharmacoepidemiology. Eur J Health Law 21:271–296. doi:10.
1136/amiajnl-2012-001575
20. Snoeren F, Hoefnagels C, Evers SM, Lamers-Winkelman F (2013)
Design of a prospective study onmental health and quality of life of
maltreated children (aged 5–16 years) after a report to an advice and
reporting center on child abuse and neglect. BMC Public Health 13:
942. doi:10.1186/1471-2458-13-942
21. Raad voor de Kinderbescherming (2011) About the Child Care and
Protection Board. Available via https://www.kinderbescherming.nl/
over_de_raad/brochures/
22. Wildeman C, Emanuel N, Leventhal JM et al (2014) The preva-
lence of confirmed maltreatment among US children, 2004 to 2011.
JAMA Pediatr 168:706–713. doi:10.1001/jamapediatrics.2014.410
23. World Medical Association WM (2013) Declaration of Helsinki -
Ethical principles for medical research involving human subjects.
Available via http://www.wma.net/en/30publications/10policies/
b3/
1578 Eur J Pediatr (2015) 174:1573–1578
